BindingDB logo
myBDB logout

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23294255 114 Development of new cyclic plasmin inhibitors with excellent potency and selectivity.EBI Philipps University Marburg
10669559 180 Protease inhibitors: current status and future prospects.EBI University of Queensland
 78 Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitorsEBI TBA
10206542 50 Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.EBI Warner-Lambert Company
9544206 94 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.EBI Warner-Lambert Company
 18 Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazolesBDB Hacettepe University